Search Results - "Ilidia, Moreira"
-
1
Diffuse large B-cell lymphoma in very elderly patients: Towards best tailored treatment – A systematic review
Published in Critical reviews in oncology/hematology (01-04-2021)“…[Display omitted] •Treatment of elderly DLBCL patients represents a particular challenge.•Most clinical trials exclude the octogenarian patients with…”
Get full text
Journal Article -
2
Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled study
Published in The Lancet. Haematology (01-08-2017)“…GP2013 is a rituximab biosimilar developed to stringent development guidelines, including non-clinical and preclinical investigations and clinical trials in…”
Get full text
Journal Article -
3
A phase 1/2, open‐label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma
Published in Hematological oncology (01-02-2023)“…Patients with relapsed or refractory lymphoma have limited treatment options, requiring newer regimens. In this Phase 1/2 study (NCT03769181), we assessed the…”
Get full text
Journal Article -
4
Diagnosis, complications and management of chronic neutrophilic leukaemia: A case report
Published in Oncology letters (01-06-2015)“…Chronic neutrophilic leukemia (CNL) is a rare myeloproliferative neoplasm characterized by sustained neutrophilia and the absence of the Philadelphia…”
Get full text
Journal Article -
5
Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution
Published in Molecular oncology (01-10-2012)“…Chromosomal rearrangements affecting the MLL gene are associated with high-risk pediatric, adult and therapy-associated acute leukemia. In this study,…”
Get full text
Journal Article -
6
Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution
Published in BMC cancer (12-12-2018)“…Most patients with chronic myeloid leukemia (CML) treated with tyrosine kinase inhibitors (TKIs) will relapse if treatment is withdrawn, but various trials…”
Get full text
Journal Article -
7
Minimal Residual Disease Tests Provide an Independent Predictor of Clinical Outcome in Adult Acute Lymphoblastic Leukemia
Published in Journal of clinical oncology (15-02-2002)Get full text
Journal Article -
8
Gastric MALT Lymphoma: A 8-Year Experience
Published in Indian journal of hematology & blood transfusion (01-07-2022)“…Gastric mucosa-associated lymphoid tissue non-Hodgkin lymphoma (gMALT NHL) is the second most common gastrointestinal lymphoma (50% of all gastric lymphomas),…”
Get full text
Journal Article -
9
Gastric Diffuse Large B-Cell Lymphoma: A Single-Center 9-Year Experience
Published in Indian journal of hematology & blood transfusion (01-07-2021)“…Gastric diffuse large B cell lymphoma (DLBCL) represents the majority of all gastric lymphomas. We report a series of gastric DLBCL diagnosed and treated in a…”
Get full text
Journal Article -
10
PB2576: NEWS, NEWS2 AND QSOFA ACCURACY TO PREDICT SEPSIS‐RELATED MORTALITY IN ACUTE MYELOID LEUKEMIA: A RETROSPECTIVE SINGLE‐CENTRE ANALYSIS
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
11
Immunoglobulin heavy-chain gene rearrangement in adult acute lymphoblastic leukemia reveals preferential usage of JH-proximal variable gene segments
Published in Blood (01-05-2001)“…The aim of this study was to characterize individual-segment and overall patterns of VH gene usage in adult B-lineage acute lymphoblastic leukemia (ALL)…”
Get full text
Journal Article -
12
Polymerase chain reaction (PCR)‐ and reverse transcription PCR‐based minimal residual disease detection in long‐term follow‐up of childhood acute lymphoblastic leukaemia
Published in British journal of haematology (01-12-2002)“…Minimal residual disease (MRD) was investigated in 52 children with acute lymphoblastic leukaemia (ALL), using antigen receptor gene rearrangements and reverse…”
Get full text
Journal Article -
13
Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia
Published in Journal of clinical oncology (15-02-2002)“…Investigation of minimal residual disease (MRD) in childhood acute lymphoblastic leukemia (ALL) using molecular markers has proven superior to other standard…”
Get full text
Journal Article -
14
Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia
Published in Oncology letters (01-07-2016)“…Therapy-related acute myeloid leukemia (t-AML) is a rare and almost always fatal late side effect of antineoplastic treatment involving chemotherapy,…”
Get full text
Journal Article -
15
Abnormal NK cell lymphocytosis detected after splenectomy: Association with repeated infections, relapsing neutropenia, and persistent polyclonal B-cell proliferation
Published in International journal of hematology (01-06-2002)“…We report the case of a boy with hereditary spherocytosis who presented with mild microcytic hypochromic anemia and recurrent leg ulcers that had been present…”
Get full text
Journal Article -
16
Bundle Approach to Reduce Bloodstream Infections in Neutropenic Hematologic Patients with a Long-Term Central Venous Catheter
Published in Acta medica portuguesa (01-07-2015)“…The objective of the study was to reduce, by a bundle of interventions, the global bloodstream infections and catheter-related bloodstream infections rates in…”
Get more information
Journal Article -
17
A Phase III Efficacy and Safety Study of the Proposed Rituximab Biosimilar GP2013 Versus Rituximab in Patients with Previously Untreated Advanced Follicular Lymphoma
Published in Blood (02-12-2016)“…Background: GP2013 is being developed as a proposed biosimilar to EU approved originator Rituximab (RTX). The stepwise global development program for GP2013 is…”
Get full text
Journal Article -
18
Bundle Approach to Reduce Bloodstream Infections in Neutropenic Hematologic
Published in Acta médica portuguesa (10-07-2015)“…Introduction: The objective of the study was to reduce, by a bundle of interventions, the global bloodstream infections and catheterrelated bloodstream…”
Get full text
Journal Article -
19
Relapsed Follicular Lymphoma Treatment - with or without Hematopoietic Stem Cell Transplant?
Published in Blood (06-12-2014)“…The best treatment strategy in patients with relapsed Follicular Lymphoma (FL) remains controversial. The incorporation of rituximab (R) in the 1st line…”
Get full text
Journal Article -
20
Advanced Stage Follicular Lymphoma - Watch and Wait or Immunochemotherapy?
Published in Blood (06-12-2014)“…The outcome of patients with advanced stage Follicular Lymphoma (FL) has improved over the last decade, with the use of monoclonal antibodies (mAbs). The watch…”
Get full text
Journal Article